AB
IMRX icon

Amalgamated Bank’s Immuneering IMRX Stock Holding History

Amalgamated Bank’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-684
Closed -$2K – 3062
2024
Q1 		$2K Sell
684
-1,927
-74% -$10.8K ﹤0.01% 2890
2023
Q4 		$19K Sell
2,611
-203
-7% -$1.35K ﹤0.01% 2678
2023
Q3 		$22K Hold
2,814
– – ﹤0.01% 2613
2023
Q2 		$29K Buy
+2,814
New +$27.1K ﹤0.01% 2547
2022
Q2 		– Sell
-1,219
Closed -$8K – 3114
2022
Q1 		$8K Buy
+1,219
New +$11.7K ﹤0.01% 2991

Other funds holding IMRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Amalgamated Bank's IMRX Position: Q2 2024 in Review

Amalgamated Bank sold out of Immuneering (IMRX) in Q2 2024, closing a stake of 684 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in IMRX in Q1 2022 and held it in 5 quarters. The position peaked at $29K in Q2 2023. 59 funds tracked by Wall St. Rank hold IMRX as of Q2 2024.

  • Amalgamated Bank reported no remaining Immuneering position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 684 Immuneering shares in Q2 2024, an estimated $2K.
  • Amalgamated Bank first reported a position in Immuneering in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Immuneering position peaked at $29K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Immuneering as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.